Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 13 Endometrial Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Breast Neoplasms 4 Neoplasms 3 Uterine Neoplasms 2 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Melanoma 1 Laryngeal Neoplasms 1 Kenny-Caffey syndrome, Type 1 1 Hyperglycemia 1 High Grade Serous Ovarian Cancer 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 Fallopian Tube Neoplasms 1

Interventions

Fulvestrant 5 Letrozole 4 Capecitabine 3 pyrotinib 2 Paclitaxel 2 Goserelin 2 Anastrozole 2 palbociclib 1 olaparib 1 neratinib 1 liposomal doxorubicin 1 exemestane 1 entinostat 1 ceralasertib 1 capivasertib 1 Vinorelbine 1 Trastuzumab 1 Standard of Care 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Injections 1 In Situ Hybridization, Fluorescence 1 Immunotherapy, Adoptive 1 Gonadotropin-Releasing Hormone 1 FCN-437c 1 Docetaxel 1 Decitabine 1 Cyclophosphamide 1 Combined Modality Therapy 1 Cisplatin 1 CYH33 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Breast Cancer × olaparib × Clear all

NCT03182634 2019-01-22

plasmaMATCH

Institute of Cancer Research, United Kingdom

Phase 2 Unknown

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡